White matter and basal ganglia hyperintensities
| DLB (n=27) | AD (n=28) | VaD (n=25) | Con (n=26) | p Value | |
|---|---|---|---|---|---|
| Frontal: | |||||
| Prevalence | 22 (81%) | 25 (89%) | 24 (96%) | 19 (73%) | |
| Median score | 2 | 2 | 3 | 1 | <0.054-150 |
| Temporal: | |||||
| Prevalence | 3 (11%) | 4 (14%) | 3 (12%) | 1 (4%) | |
| Median score | 0 | 0 | 0 | 0 | NS |
| Parietal: | |||||
| Prevalence | 15 (56%) | 13 (46%) | 19 (76%) | 8 (31%) | |
| Median score | 1 | 0 | 3 | 0 | <0.014-151 |
| Occipital: | |||||
| Prevalence | 2 (7%) | 3 (11%) | 6 (24%) | 3 (12%) | |
| Median score | 0 | 0 | 0 | 0 | NS |
| Basal ganglia | |||||
| prevalence | 7 (26%) | 6 (21%) | 17 (68%) | 3 (12%) | |
| median score | 0 | 0 | 2 | 0 | <0.0014-152 |
| Total | |||||
| prevalence | 23 (85%) | 25 (89%) | 24 (96%) | 19 (73%) | |
| median score | 3 | 4 | 8 | 1 | <0.0014-153 |
For abbreviations see table 2.
Post hoc Mann-Whitney U test showed significant differences between:
↵4-150 Con and AD (p<0.05) and between Con and VaD (p<0.01)
↵4-151 Con and DLB, Con and AD (p<0.05), and between Con and VaD (p<0.001)
↵4-152 VaD and all other groups (p<0.001)
↵4-153 Con and DLB, Con and AD, VaD and DLB (p<0.05), between VaD and AD (p<0.01), and between VaD and Con (p<0.001)